Get the Stockscreener App
24.49
4.52%
1.06
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Perrigo Company Plc stock is traded at $24.49, with a volume of 2.47M.
It is up +4.52% in the last 24 hours and down -11.11% over the past month.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
See More
Previous Close:
$23.43
Open:
$23.72
24h Volume:
2.47M
Relative Volume:
1.97
Market Cap:
$3.37B
Revenue:
$4.39B
Net Income/Loss:
$-159.70M
P/E Ratio:
-20.93
EPS:
-1.17
Net Cash Flow:
$151.70M
1W Performance:
+7.89%
1M Performance:
-11.11%
6M Performance:
-3.35%
1Y Performance:
-12.97%
1-Day Range:
$23.69
$24.61
1-Week Range:
$22.70
$24.61
52-Week Range:
$21.03
$30.93
Perrigo Company Plc Stock (PRGO) Company Profile
Name
Perrigo Company Plc
Sector
Phone
269-673-8451
Address
THE SHARP BUILDING, DUBLIN 2
Compare PRGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
24.49 | 3.17B | 4.39B | -159.70M | 151.70M | -1.17 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-25 | Downgrade | Argus | Buy → Hold |
| Jan-06-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-24-24 | Resumed | Jefferies | Hold |
| Nov-17-23 | Initiated | Piper Sandler | Overweight |
| Mar-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-14-22 | Upgrade | Argus | Hold → Buy |
| Sep-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-14-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-30-21 | Upgrade | Jefferies | Hold → Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Jan-06-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-17-20 | Downgrade | Argus | Buy → Hold |
| Mar-24-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-20-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-18-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-11-19 | Upgrade | Argus | Hold → Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Nov-13-18 | Downgrade | Berenberg | Buy → Hold |
| Aug-10-18 | Reiterated | Stifel | Hold |
| Jul-30-18 | Downgrade | Argus | Buy → Hold |
| Jul-12-18 | Downgrade | Goldman | Neutral → Sell |
| Jan-03-18 | Initiated | Leerink Partners | Mkt Perform |
| Dec-08-17 | Upgrade | Argus | Hold → Buy |
| Nov-10-17 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Oct-05-17 | Reiterated | UBS | Buy |
| Sep-07-17 | Initiated | Oppenheimer | Outperform |
| Aug-11-17 | Upgrade | Goldman | Sell → Neutral |
| Aug-11-17 | Reiterated | RBC Capital Mkts | Underperform |
| Jun-16-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-05-17 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| Mar-03-17 | Reiterated | B. Riley & Co. | Neutral |
View All
Perrigo Company Plc Stock (PRGO) Latest News
Leading OTC Healthcare Provider Perrigo to Present at Barclays Consumer Staples Conference 2025 - Stock Titan
Russell Investments Group Ltd. Has $22.21 Million Stake in Perrigo Company plc $PRGO - MarketBeat
Vanguard Group Inc. Sells 904,531 Shares of Perrigo Company plc $PRGO - MarketBeat
Perrigo director Parker buys $100k in company stock - Investing.com
Invesco Ltd. Grows Stock Holdings in Perrigo Company plc $PRGO - MarketBeat
Aigen Investment Management LP Takes $347,000 Position in Perrigo Company plc $PRGO - MarketBeat
US Bancorp DE Increases Stock Holdings in Perrigo Company plc (NYSE:PRGO) - MarketBeat
Arrowpoint Investment Partners Singapore Pte. Ltd. Makes New Investment in Perrigo Company plc (NYSE:PRGO) - MarketBeat
STATE STREET CORP Increases Stake in Perrigo Co PLC - GuruFocus
Perrigo Company plc Included in Top Momentum ScanQuarterly Risk Review & Capital Efficiency Focused Ideas - beatles.ru
Perrigo Company plc Reversal Rally May Surprise BearsWall Street Watch & Weekly Breakout Stock Alerts - newsimpact.co.kr
Ethiraj Purushothaman Joins Perrigo as Global Head of Data, Analytics and AI - CDO Magazine
Perrigo Company: Strong Execution and Growth Prospects Support Buy Rating - AInvest
Can Perrigo's (PRGO) Profitability Focus Offset Sales Pressure in Its 2025 Outlook? - simplywall.st
Perrigo Company shares rise 1.17% after-hours following a presentation at Canaccord Genuity's event. - AInvest
Jefferies Financial Group Inc. Buys New Stake in Perrigo Company plc (NYSE:PRGO) - MarketBeat
How Perrigo Company plc stock performs during market volatilityHigh Momentum Winner List - mustnews.co.kr
Transcript : Perrigo Company plc Presents at Canaccord Genuity?s 45th Annual Growth Conference, Aug-12-2025 09 - MarketScreener
Is Perrigo Company plc a top pick in the sectorExplosive Small Cap Picks - thegnnews.com
Brokerages Set Perrigo Company plc (NYSE:PRGO) PT at $33.00 - MarketBeat
Are Investors Undervaluing Perrigo (PRGO) Right Now? - Yahoo Finance
Trendlines Suggest Perrigo Company plc May Bottom Out SoonHigh Return Stock Focus With Safety Emphasized - beatles.ru
Perrigo Company Reports Mixed Q2 2025 Results - TipRanks
Canaccord Genuity Lowers Perrigo's Price Target to $40.00, Maintains "Buy" Rating. - AInvest
Perrigo (NYSE:PRGO) Sets New 12-Month Low After Earnings Miss - MarketBeat
PERRIGO Co plc Director CEO Lockwood-Taylor buys 4060 shares at $22.37/share. - AInvest
Burn Pain Market: Epidemiology, Therapies, Companies, DelveInsight | Johnson & Johnson, Mankind Pharma, Perrigo Company PLC, Pfizer Inc., Smith & Nephew PLC, Sun Pharmaceutical Industries Ltd, Trio Li - Barchart.com
Perrigo outlines $2.90–$3.10 EPS target and reaffirms full-year guidance amid strategic divestitures and brand share gains - MSN
Perrigo Company plc (NYSE:PRGO) Q2 2025 Earnings Call Transcript - Insider Monkey
Perrigo's Q2 Earnings Call Highlights Growth Amid Challenges, Affirms Full-Year EPS Outlook - AInvest
Perrigo Outlines $2.90-$3.10 EPS Target, Reaffirms FY Guidance Amid Divestitures and Brand Share Gains - AInvest
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut - Yahoo Finance
Perrigo stock hits 52-week low at $22.26 By Investing.com - Investing.com Nigeria
Perrigo Company PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Perrigo Company plc Reaffirms Earnings Guidance for the Fiscal Year 2025 - MarketScreener
Perrigo's Strategic Reinvention: A Case for Long-Term Growth in the OTC Self-Care Sector - AInvest
Perrigo shares rise 3% as company reaffirms full-year outlook despite challenging market - Investing.com Nigeria
Earnings Flash (PRGO) Perrigo Company plc Reports Q2 Revenue $1.06B, vs. FactSet Est of $1.08B - MarketScreener
Earnings Flash (PRGO) Perrigo Company plc Posts Q2 Adjusted EPS $0.57 per Share, vs. FactSet Est of $0.59 - MarketScreener
Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations – Company Announcement - Financial Times
XTX Topco Ltd Makes New $1.41 Million Investment in Perrigo Company plc (NYSE:PRGO) - MarketBeat
What is the risk reward ratio of investing in Perrigo Company plc stockBreakthrough profits - Jammu Links News
Is Perrigo Company plc a good long term investmentCapitalize on market momentum for maximum gains - Jammu Links News
Perrigo Company plc (NYSE:PRGO) Announces Quarterly Dividend of $0.29 - MarketBeat
Monaco Asset Management SAM Acquires 22,500 Shares of Perrigo Company plc (NYSE:PRGO) - MarketBeat
How many analysts rate Perrigo Company plc as a “Buy”Powerful profit generation - Jammu Links News
How does Perrigo Company plc generate profit in a changing economyBuild wealth steadily with proven stock picks - Jammu Links News
Should I hold or sell Perrigo Company plc stock in 2025Maximize portfolio growth with strategic plans - Jammu Links News
Perrigo Company Plc Stock (PRGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Perrigo Company Plc Stock (PRGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bezerra Eduardo Guarita | EVP & Chief Financial Officer |
Aug 18 '25 |
Buy |
22.74 |
3,000 |
68,207 |
48,949 |
| Lockwood-Taylor Patrick | CEO |
Aug 08 '25 |
Buy |
22.37 |
4,460 |
99,766 |
85,812 |
| Lockwood-Taylor Patrick | CEO |
Jul 10 '25 |
Option Exercise |
27.27 |
28,326 |
772,450 |
95,586 |
| Bezerra Eduardo Guarita | EVP & Chief Financial Officer |
Jun 06 '25 |
Option Exercise |
26.16 |
4,531 |
118,531 |
47,732 |
| Khoury Roberto | EVP and President of CSCI |
Jun 06 '25 |
Option Exercise |
26.16 |
10,868 |
284,307 |
7,888 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):